Gilead Sciences Other Non-Current Assets increased by 1132.8% to $4.85B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 21.2%, from $6.15B to $4.85B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows a downward trend with a -3.2% CAGR.
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Often contains strategic minority investments in technology partners or long-term tax-related items.
other_non_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.55B | $4.74B | $4.96B | $5.13B | $4.86B | $4.62B | $4.80B | $4.95B | $5.11B | $4.20B | $4.79B | $359.00M | $376.00M | $382.00M | $6.15B | $359.00M | $369.00M | $393.00M | $4.85B |
| QoQ Change | — | -14.6% | +4.7% | +3.3% | -5.2% | -5.0% | +3.9% | +3.2% | +3.3% | -17.9% | +14.1% | -92.5% | +4.7% | +1.6% | >999% | -94.2% | +2.8% | +6.5% | >999% |
| YoY Change | — | — | — | — | -12.5% | -2.6% | -3.3% | -3.4% | +5.2% | -9.1% | -0.2% | -92.8% | -92.6% | -90.9% | +28.3% | +0.0% | -1.9% | +2.9% | -21.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.